{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:41:58Z","timestamp":1793108518984,"version":"4.5.0"},"reference-count":289,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41577-026-01313-2","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:52:26Z","timestamp":1780491146000},"page":"817-836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Glial cells in chronic inflammation: diversity, dysfunction and therapeutic targeting"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5960-5504","authenticated-orcid":false,"given":"Hong-Gyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Rone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6249-4291","authenticated-orcid":false,"given":"Joon-Hyuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8156-0736","authenticated-orcid":false,"given":"Francisco J.","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"1313_CR1","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton, C. et al. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult. Scler. 26, 1816\u20131821 (2020).","journal-title":"Mult. Scler."},{"key":"1313_CR2","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1016\/j.neuron.2024.05.025","volume":"112","author":"T Garton","year":"2024","unstructured":"Garton, T., Gadani, S. P., Gill, A. J. & Calabresi, P. A. Neurodegeneration and demyelination in multiple sclerosis. Neuron 112, 3231\u20133251 (2024).","journal-title":"Neuron"},{"key":"1313_CR3","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1001\/jamaneurol.2020.1568","volume":"77","author":"L Kappos","year":"2020","unstructured":"Kappos, L. et al. Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled analysis of 2 randomized clinical trials. JAMA Neurol. 77, 1132\u20131140 (2020).","journal-title":"JAMA Neurol."},{"key":"1313_CR4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/457675a","volume":"457","author":"NJ Allen","year":"2009","unstructured":"Allen, N. J. & Barres, B. A. Neuroscience: glia \u2014 more than just brain glue. Nature 457, 675\u2013677 (2009).","journal-title":"Nature"},{"key":"1313_CR5","doi-asserted-by":"publisher","first-page":"eadi7828","DOI":"10.1126\/scitranslmed.adi7828","volume":"15","author":"HG Lee","year":"2023","unstructured":"Lee, H. G., Lee, J. H., Flausino, L. E. & Quintana, F. J. Neuroinflammation: an astrocyte perspective. Sci. Transl. Med. 15, eadi7828 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1313_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41573-022-00390-x","volume":"21","author":"HG Lee","year":"2022","unstructured":"Lee, H. G., Wheeler, M. A. & Quintana, F. J. Function and therapeutic value of astrocytes in neurological diseases. Nat. Rev. Drug Discov. 21, 339\u2013358 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1313_CR7","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.celrep.2020.01.010","volume":"30","author":"T Masuda","year":"2020","unstructured":"Masuda, T., Sankowski, R., Staszewski, O. & Prinz, M. Microglia heterogeneity in the single-cell era. Cell Rep. 30, 1271\u20131281 (2020).","journal-title":"Cell Rep."},{"key":"1313_CR8","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1126\/science.aaf6463","volume":"352","author":"S Marques","year":"2016","unstructured":"Marques, S. et al. Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system. Science 352, 1326\u20131329 (2016). This study pioneered analysis of the molecular heterogeneity of oligodendroglia in the healthy mouse CNS.","journal-title":"Science"},{"key":"1313_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41586-019-0903-2","volume":"566","author":"S J\u00e4kel","year":"2019","unstructured":"J\u00e4kel, S. et al. Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature 566, 543\u2013547 (2019). This work was the first to address oligodendroglial heterogeneity in human MS.","journal-title":"Nature"},{"key":"1313_CR10","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.cell.2023.03.008","volume":"186","author":"M Charabati","year":"2023","unstructured":"Charabati, M., Wheeler, M. A., Weiner, H. L. & Quintana, F. J. Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting. Cell 186, 1309\u20131327 (2023).","journal-title":"Cell"},{"key":"1313_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104220","volume":"68","author":"H Tedeholm","year":"2022","unstructured":"Tedeholm, H. et al. Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis. Mult. Scler. Relat. Disord. 68, 104220 (2022).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1313_CR12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1474-4422(07)70243-0","volume":"6","author":"DH Miller","year":"2007","unstructured":"Miller, D. H. & Leary, S. M. Primary-progressive multiple sclerosis. Lancet Neurol. 6, 903\u2013912 (2007).","journal-title":"Lancet Neurol."},{"key":"1313_CR13","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/ana.24497","volume":"78","author":"JM Frischer","year":"2015","unstructured":"Frischer, J. M. et al. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann. Neurol. 78, 710\u2013721 (2015).","journal-title":"Ann. Neurol."},{"key":"1313_CR14","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.expneurol.2012.07.009","volume":"237","author":"K Sharma","year":"2012","unstructured":"Sharma, K., Selzer, M. E. & Li, S. Scar-mediated inhibition and CSPG receptors in the CNS. Exp. Neurol. 237, 370\u2013378 (2012).","journal-title":"Exp. Neurol."},{"key":"1313_CR15","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1093\/brain\/awab059","volume":"144","author":"S Ghorbani","year":"2021","unstructured":"Ghorbani, S. & Yong, V. W. The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis. Brain 144, 1958\u20131973 (2021).","journal-title":"Brain"},{"key":"1313_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/17562864211066751","volume":"15","author":"G Giovannoni","year":"2022","unstructured":"Giovannoni, G. et al. Smouldering multiple sclerosis: the \u2018real MS\u2019. Ther. Adv. Neurol. Disord. 15, 17562864211066751 (2022).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"1313_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","volume":"22","author":"T Kuhlmann","year":"2023","unstructured":"Kuhlmann, T. et al. Multiple sclerosis progression: time for a new mechanism-driven framework. Lancet Neurol. 22, 78\u201388 (2023).","journal-title":"Lancet Neurol."},{"key":"1313_CR18","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1001\/jamaneurol.2019.2399","volume":"76","author":"M Absinta","year":"2019","unstructured":"Absinta, M. et al. Association of chronic active multiple sclerosis lesions with disability in vivo. JAMA Neurol. 76, 1474\u20131483 (2019).","journal-title":"JAMA Neurol."},{"key":"1313_CR19","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1038\/s41591-025-03625-7","volume":"31","author":"L Klotz","year":"2025","unstructured":"Klotz, L. et al. Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis. Nat. Med. 31, 2016\u20132026 (2025).","journal-title":"Nat. Med."},{"key":"1313_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22265-2","volume":"12","author":"A Eshaghi","year":"2021","unstructured":"Eshaghi, A. et al. Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data. Nat. Commun. 12, 2078 (2021).","journal-title":"Nat. Commun."},{"key":"1313_CR21","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1038\/s41591-025-03901-6","volume":"31","author":"H Ganjgahi","year":"2025","unstructured":"Ganjgahi, H. et al. AI-driven reclassification of multiple sclerosis progression. Nat. Med. 31, 3414\u20133424 (2025).","journal-title":"Nat. Med."},{"key":"1313_CR22","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41573-019-0035-2","volume":"18","author":"S Faissner","year":"2019","unstructured":"Faissner, S., Plemel, J. R., Gold, R. & Yong, V. W. Progressive multiple sclerosis: from pathophysiology to therapeutic strategies. Nat. Rev. Drug Discov. 18, 905\u2013922 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1313_CR23","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s40265-021-01526-w","volume":"81","author":"N Huntemann","year":"2021","unstructured":"Huntemann, N. et al. Failed, interrupted, or inconclusive trials on neuroprotective and neuroregenerative treatment strategies in multiple sclerosis: update 2015-2020. Drugs 81, 1031\u20131063 (2021).","journal-title":"Drugs"},{"key":"1313_CR24","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.tcb.2023.09.006","volume":"34","author":"KT Baldwin","year":"2024","unstructured":"Baldwin, K. T., Murai, K. K. & Khakh, B. S. Astrocyte morphology. Trends Cell Biol. 34, 547\u2013565 (2024).","journal-title":"Trends Cell Biol."},{"key":"1313_CR25","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41593-024-01684-6","volume":"27","author":"TM O\u2019Shea","year":"2024","unstructured":"O\u2019Shea, T. M. et al. Derivation and transcriptional reprogramming of border-forming wound repair astrocytes after spinal cord injury or stroke in mice. Nat. Neurosci. 27, 1505\u20131521 (2024).","journal-title":"Nat. Neurosci."},{"key":"1313_CR26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/glia.24494","volume":"72","author":"P Prakash","year":"2024","unstructured":"Prakash, P. et al. Proteomic profiling of interferon-responsive reactive astrocytes in rodent and human. Glia 72, 625\u2013642 (2024).","journal-title":"Glia"},{"key":"1313_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-020-1999-0","volume":"578","author":"MA Wheeler","year":"2020","unstructured":"Wheeler, M. A. et al. MAFG-driven astrocytes promote CNS inflammation. Nature 578, 593\u2013599 (2020). The first study to define astrocyte heterogeneity at single-cell resolution in MS and EAE.","journal-title":"Nature"},{"key":"1313_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41586-019-1404-z","volume":"573","author":"L Schirmer","year":"2019","unstructured":"Schirmer, L. et al. Neuronal vulnerability and multilineage diversity in multiple sclerosis. Nature 573, 75\u201382 (2019).","journal-title":"Nature"},{"key":"1313_CR29","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","volume":"597","author":"M Absinta","year":"2021","unstructured":"Absinta, M. et al. A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis. Nature 597, 709\u2013714 (2021). This elegant work mapped lymphocyte\u2013microglia astrocyte interactions in chronic active MS lesions.","journal-title":"Nature"},{"key":"1313_CR30","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1038\/s41593-024-01796-z","volume":"27","author":"C Lerma-Martin","year":"2024","unstructured":"Lerma-Martin, C. et al. Cell type mapping reveals tissue niches and interactions in subcortical multiple sclerosis lesions. Nat. Neurosci. 27, 2354\u20132365 (2024).","journal-title":"Nat. Neurosci."},{"key":"1313_CR31","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1038\/s41593-024-01765-6","volume":"27","author":"AM Alsema","year":"2024","unstructured":"Alsema, A. M. et al. Spatially resolved gene signatures of white matter lesion progression in multiple sclerosis. Nat. Neurosci. 27, 2341\u20132353 (2024).","journal-title":"Nat. Neurosci."},{"key":"1313_CR32","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.cell.2024.02.030","volume":"187","author":"P Kukanja","year":"2024","unstructured":"Kukanja, P. et al. Cellular architecture of evolving neuroinflammatory lesions and multiple sclerosis pathology. Cell 187, 1990\u20132009.e19 (2024). This work applied in situ sequencing and single-cell spatial mapping for the first time to define the spatial relationship between glial cells and infiltrating immune cells, broadening our understanding of MS pathology.","journal-title":"Cell"},{"key":"1313_CR33","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1126\/science.abq4822","volume":"379","author":"MA Wheeler","year":"2023","unstructured":"Wheeler, M. A. et al. Droplet-based forward genetic screening of astrocyte-microglia cross-talk. Science 379, 1023\u20131030 (2023).","journal-title":"Science"},{"key":"1313_CR34","doi-asserted-by":"publisher","first-page":"eabf1230","DOI":"10.1126\/science.abf1230","volume":"372","author":"IC Clark","year":"2021","unstructured":"Clark, I. C. et al. Barcoded viral tracing of single-cell interactions in central nervous system inflammation. Science 372, eabf1230 (2021). This study describes a novel approach to the study of cell\u2013cell interactions in vivo single-cell resolution.","journal-title":"Science"},{"key":"1313_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41582-025-01081-y","volume":"21","author":"MS van der Knaap","year":"2025","unstructured":"van der Knaap, M. S. & Min, R. Multiple sclerosis: an immune attack on astrocyte-mediated ion and water homeostasis. Nat. Rev. Neurol. 21, 283\u2013289 (2025).","journal-title":"Nat. Rev. Neurol."},{"key":"1313_CR36","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41582-024-01014-1","volume":"20","author":"A Uzawa","year":"2024","unstructured":"Uzawa, A., Oertel, F. C., Mori, M., Paul, F. & Kuwabara, S. NMOSD and MOGAD: an evolving disease spectrum. Nat. Rev. Neurol. 20, 602\u2013619 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"1313_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16284","volume":"31","author":"C Hagbohm","year":"2024","unstructured":"Hagbohm, C. et al. Clinical and neuroimaging phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy: a systematic review and meta-analysis. Eur. J. Neurol. 31, e16284 (2024).","journal-title":"Eur. J. Neurol."},{"key":"1313_CR38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487 (2017).","journal-title":"Nature"},{"key":"1313_CR39","doi-asserted-by":"publisher","first-page":"a032003","DOI":"10.1101\/cshperspect.a032003","volume":"8","author":"D Jakimovski","year":"2018","unstructured":"Jakimovski, D., Kolb, C., Ramanathan, M., Zivadinov, R. & Weinstock-Guttman, B. Interferon \u03b2 for multiple sclerosis. Cold Spring Harb. Perspect. Med. 8, a032003 (2018).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"1313_CR40","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.immuni.2008.03.011","volume":"28","author":"M Prinz","year":"2008","unstructured":"Prinz, M. et al. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 28, 675\u2013686 (2008).","journal-title":"Immunity"},{"key":"1313_CR41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jconrel.2020.11.019","volume":"331","author":"LF Gonz\u00e1lez","year":"2021","unstructured":"Gonz\u00e1lez, L. F. et al. Intranasal delivery of interferon-\u03b2-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: a promising simple, effective, non-invasive, and low-cost therapy. J. Control. Rel. 331, 443\u2013459 (2021).","journal-title":"J. Control. Rel."},{"key":"1313_CR42","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nm.4106","volume":"22","author":"V Rothhammer","year":"2016","unstructured":"Rothhammer, V. et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 22, 586\u2013597 (2016).","journal-title":"Nat. Med."},{"key":"1313_CR43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00401-015-1418-z","volume":"130","author":"R Khorooshi","year":"2015","unstructured":"Khorooshi, R. et al. Induction of endogenous type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis. Acta Neuropathol. 130, 107\u2013118 (2015).","journal-title":"Acta Neuropathol."},{"key":"1313_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042088","volume":"7","author":"C Hindinger","year":"2012","unstructured":"Hindinger, C. et al. IFN-\u03b3 signaling to astrocytes protects from autoimmune mediated neurological disability. PLoS One 7, e42088 (2012).","journal-title":"PLoS One"},{"key":"1313_CR45","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41586-020-03116-4","volume":"590","author":"LM Sanmarco","year":"2021","unstructured":"Sanmarco, L. M. et al. Gut-licensed IFN\u03b3+ NK cells drive LAMP1+ TRAIL+ anti-inflammatory astrocytes. Nature 590, 473\u2013479 (2021).","journal-title":"Nature"},{"key":"1313_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02917-4","volume":"20","author":"BC Smith","year":"2023","unstructured":"Smith, B. C. et al. Astrocyte interferon-gamma signaling dampens inflammation during chronic central nervous system autoimmunity via PD-L1. J. Neuroinflammation 20, 234 (2023).","journal-title":"J. Neuroinflammation"},{"key":"1313_CR47","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/s41593-022-01180-9","volume":"25","author":"K Leng","year":"2022","unstructured":"Leng, K. et al. CRISPRi screens in human iPSC-derived astrocytes elucidate regulators of distinct inflammatory reactive states. Nat. Neurosci. 25, 1528\u20131542 (2022).","journal-title":"Nat. Neurosci."},{"key":"1313_CR48","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.3681","volume":"20","author":"L Mayo","year":"2014","unstructured":"Mayo, L. et al. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat. Med. 20, 1147\u20131156 (2014).","journal-title":"Nat. Med."},{"key":"1313_CR49","doi-asserted-by":"publisher","first-page":"679","DOI":"10.5483\/BMBRep.2014.47.12.018","volume":"47","author":"JK Choi","year":"2014","unstructured":"Choi, J. K. et al. GM-CSF reduces expression of chondroitin sulfate proteoglycan (CSPG) core proteins in TGF-\u03b2-treated primary astrocytes. BMB Rep. 47, 679\u2013684 (2014).","journal-title":"BMB Rep."},{"key":"1313_CR50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/(SICI)1098-1136(199601)16:1<71::AID-GLIA8>3.0.CO;2-E","volume":"16","author":"G Guillemin","year":"1996","unstructured":"Guillemin, G. et al. Granulocyte macrophage colony stimulating factor stimulates in vitro proliferation of astrocytes derived from simian mature brains. Glia 16, 71\u201380 (1996).","journal-title":"Glia"},{"key":"1313_CR51","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.immuni.2015.08.010","volume":"43","author":"AL Croxford","year":"2015","unstructured":"Croxford, A. L. et al. The cytokine GM-CSF drives the inflammatory signature of CCR2+ monocytes and licenses autoimmunity. Immunity 43, 502\u2013514 (2015).","journal-title":"Immunity"},{"key":"1313_CR52","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.immuni.2021.01.004","volume":"54","author":"ME Deerhake","year":"2021","unstructured":"Deerhake, M. E. et al. Dectin-1 limits autoimmune neuroinflammation and promotes myeloid cell-astrocyte crosstalk via Card9-independent expression of Oncostatin M. Immunity 54, 484\u2013498.e488 (2021).","journal-title":"Immunity"},{"key":"1313_CR53","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1073\/pnas.1912910117","volume":"117","author":"E Houben","year":"2020","unstructured":"Houben, E. et al. Oncostatin M-induced astrocytic tissue inhibitor of metalloproteinases-1 drives remyelination. Proc. Natl Acad. Sci. USA 117, 5028\u20135038 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1313_CR54","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrn.2018.19","volume":"19","author":"PJ Magistretti","year":"2018","unstructured":"Magistretti, P. J. & Allaman, I. Lactate in the brain: from metabolic end-product to signalling molecule. Nat. Rev. Neurosci. 19, 235\u2013249 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"1313_CR55","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.cell.2019.11.016","volume":"179","author":"CC Chao","year":"2019","unstructured":"Chao, C. C. et al. Metabolic control of astrocyte pathogenic activity via cPLA2-MAVS. Cell 179, 1483\u20131498.e22 (2019).","journal-title":"Cell"},{"key":"1313_CR56","doi-asserted-by":"publisher","first-page":"10557","DOI":"10.1073\/pnas.1820466116","volume":"116","author":"Z Chen","year":"2019","unstructured":"Chen, Z. et al. Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain. Proc. Natl Acad. Sci. USA 116, 10557\u201310562 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1313_CR57","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s40478-023-01633-7","volume":"11","author":"SM Crivelli","year":"2023","unstructured":"Crivelli, S. M. et al. Inhibition of acid sphingomyelinase reduces reactive astrocyte secretion of mitotoxic extracellular vesicles and improves Alzheimer\u2019s disease pathology in the 5xFAD mouse. Acta Neuropathol. Commun. 11, 135 (2023).","journal-title":"Acta Neuropathol. Commun."},{"key":"1313_CR58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2211310119","volume":"119","author":"T Meyer","year":"2022","unstructured":"Meyer, T. et al. NAD+ metabolism drives astrocyte proinflammatory reprogramming in central nervous system autoimmunity. Proc. Natl Acad. Sci. USA 119, e2211310119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1313_CR59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/jnc.15044","volume":"158","author":"M Alaamery","year":"2021","unstructured":"Alaamery, M. et al. Role of sphingolipid metabolism in neurodegeneration. J. Neurochem. 158, 25\u201335 (2021).","journal-title":"J. Neurochem."},{"key":"1313_CR60","doi-asserted-by":"publisher","first-page":"eaav0492","DOI":"10.1126\/sciimmunol.aav0492","volume":"4","author":"P Mastorakos","year":"2019","unstructured":"Mastorakos, P. & McGavern, D. The anatomy and immunology of vasculature in the central nervous system. Sci. Immunol. 4, eaav0492 (2019).","journal-title":"Sci. Immunol."},{"key":"1313_CR61","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1523\/JNEUROSCI.4731-13.2014","volume":"34","author":"HS Kwon","year":"2014","unstructured":"Kwon, H. S., Nakaya, N., Abu-Asab, M., Kim, H. S. & Tomarev, S. I. Myocilin is involved in NgR1\/Lingo-1-mediated oligodendrocyte differentiation and myelination of the optic nerve. J. Neurosci. 34, 5539\u20135551 (2014).","journal-title":"J. Neurosci."},{"key":"1313_CR62","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1006\/bbrc.2000.3591","volume":"276","author":"S Noda","year":"2000","unstructured":"Noda, S. et al. Myocilin expression in the astrocytes of the optic nerve head. Biochem. Biophys. Res. Commun. 276, 1129\u20131135 (2000).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1313_CR63","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1523\/JNEUROSCI.4178-07.2008","volume":"28","author":"JD Cahoy","year":"2008","unstructured":"Cahoy, J. D. et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28, 264\u2013278 (2008).","journal-title":"J. Neurosci."},{"key":"1313_CR64","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1006\/exer.2001.1063","volume":"73","author":"CS Ricard","year":"2001","unstructured":"Ricard, C. S., Agapova, O. A., Salvador-Silva, M., Kaufman, P. L. & Hernandez, M. R. Expression of myocilin\/TIGR in normal and glaucomatous primate optic nerves. Exp. Eye Res. 73, 433\u2013447 (2001).","journal-title":"Exp. Eye Res."},{"key":"1313_CR65","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1044-7431(03)00019-8","volume":"23","author":"MJ Jurynec","year":"2003","unstructured":"Jurynec, M. J. et al. TIGR is upregulated in the chronic glial scar in response to central nervous system injury and inhibits neurite outgrowth. Mol. Cell Neurosci. 23, 69\u201380 (2003).","journal-title":"Mol. Cell Neurosci."},{"key":"1313_CR66","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1002\/alz.12821","volume":"19","author":"EL Castranio","year":"2023","unstructured":"Castranio, E. L. et al. Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 19, 2239\u20132252 (2023).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1313_CR67","doi-asserted-by":"publisher","first-page":"eadc9020","DOI":"10.1126\/science.adc9020","volume":"378","author":"F Endo","year":"2022","unstructured":"Endo, F. et al. Molecular basis of astrocyte diversity and morphology across the CNS in health and disease. Science 378, eadc9020 (2022).","journal-title":"Science"},{"key":"1313_CR68","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41593-021-00905-6","volume":"24","author":"P Hasel","year":"2021","unstructured":"Hasel, P., Rose, I. V. L., Sadick, J. S., Kim, R. D. & Liddelow, S. A. Neuroinflammatory astrocyte subtypes in the mouse brain. Nat. Neurosci. 24, 1475\u20131487 (2021).","journal-title":"Nat. Neurosci."},{"key":"1313_CR69","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.stem.2020.07.006","volume":"27","author":"M Zamboni","year":"2020","unstructured":"Zamboni, M., Llorens-Bobadilla, E., Magnusson, J. P. & Fris\u00e9n, J. A widespread neurogenic potential of neocortical astrocytes is induced by injury. Cell Stem Cell 27, 605\u2013617.e5 (2020).","journal-title":"Cell Stem Cell"},{"key":"1313_CR70","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","volume":"26","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease. Nat. Med. 26, 131\u2013142 (2020).","journal-title":"Nat. Med."},{"key":"1313_CR71","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","volume":"23","author":"N Habib","year":"2020","unstructured":"Habib, N. et al. Disease-associated astrocytes in Alzheimer\u2019s disease and aging. Nat. Neurosci. 23, 701\u2013706 (2020).","journal-title":"Nat. Neurosci."},{"key":"1313_CR72","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s42003-022-03128-y","volume":"5","author":"M MacLean","year":"2022","unstructured":"MacLean, M., L\u00f3pez-D\u00edez, R., Vasquez, C., Gugger, P. F. & Schmidt, A. M. Neuronal-glial communication perturbations in murine SOD1(G93A) spinal cord. Commun. Biol. 5, 177 (2022).","journal-title":"Commun. Biol."},{"key":"1313_CR73","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2025102118","volume":"118","author":"L Mifflin","year":"2021","unstructured":"Mifflin, L. et al. A RIPK1-regulated inflammatory microglial state in amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 118, e2025102118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1313_CR74","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210040","volume":"218","author":"LM Milich","year":"2021","unstructured":"Milich, L. M. et al. Single-cell analysis of the cellular heterogeneity and interactions in the injured mouse spinal cord. J. Exp. Med. 218, e20210040 (2021).","journal-title":"J. Exp. Med."},{"key":"1313_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33184-1","volume":"13","author":"KJE Matson","year":"2022","unstructured":"Matson, K. J. E. et al. Single cell atlas of spinal cord injury in mice reveals a pro-regenerative signature in spinocerebellar neurons. Nat. Commun. 13, 5628 (2022).","journal-title":"Nat. Commun."},{"key":"1313_CR76","doi-asserted-by":"publisher","first-page":"115344","DOI":"10.1016\/j.celrep.2025.115344","volume":"44","author":"P Hasel","year":"2025","unstructured":"Hasel, P. et al. Defining the molecular identity and morphology of glia limitans superficialis astrocytes in vertebrates. Cell Rep. 44, 115344 (2025).","journal-title":"Cell Rep."},{"key":"1313_CR77","doi-asserted-by":"publisher","first-page":"13216","DOI":"10.1074\/jbc.M111.224063","volume":"287","author":"MK Joe","year":"2012","unstructured":"Joe, M. K., Kee, C. & Tomarev, S. I. Myocilin interacts with syntrophins and is member of dystrophin-associated protein complex. J. Biol. Chem. 287, 13216\u201313227 (2012).","journal-title":"J. Biol. Chem."},{"key":"1313_CR78","doi-asserted-by":"publisher","first-page":"26357","DOI":"10.1074\/jbc.M112.446138","volume":"288","author":"HS Kwon","year":"2013","unstructured":"Kwon, H. S. et al. Myocilin mediates myelination in the peripheral nervous system through ErbB2\/3 signaling. J. Biol. Chem. 288, 26357\u201326371 (2013).","journal-title":"J. Biol. Chem."},{"key":"1313_CR79","doi-asserted-by":"publisher","first-page":"16882","DOI":"10.1074\/jbc.M112.422972","volume":"288","author":"HS Kwon","year":"2013","unstructured":"Kwon, H. S., Johnson, T. V. & Tomarev, S. I. Myocilin stimulates osteogenic differentiation of mesenchymal stem cells through mitogen-activated protein kinase signaling. J. Biol. Chem. 288, 16882\u201316894 (2013).","journal-title":"J. Biol. Chem."},{"key":"1313_CR80","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cell.2018.12.012","volume":"176","author":"MA Wheeler","year":"2019","unstructured":"Wheeler, M. A. et al. Environmental control of astrocyte pathogenic activities in CNS inflammation. Cell 176, 581\u2013596.e8 (2019).","journal-title":"Cell"},{"key":"1313_CR81","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41586-022-05613-0","volume":"614","author":"IC Clark","year":"2023","unstructured":"Clark, I. C. et al. Identification of astrocyte regulators by nucleic acid cytometry. Nature 614, 326\u2013333 (2023).","journal-title":"Nature"},{"key":"1313_CR82","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202715","volume":"218","author":"LM Sanmarco","year":"2021","unstructured":"Sanmarco, L. M., Polonio, C. M., Wheeler, M. A. & Quintana, F. J. Functional immune cell-astrocyte interactions. J. Exp. Med. 218, e20202715 (2021).","journal-title":"J. Exp. Med."},{"key":"1313_CR83","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41586-018-0119-x","volume":"557","author":"V Rothhammer","year":"2018","unstructured":"Rothhammer, V. et al. Microglial control of astrocytes in response to microbial metabolites. Nature 557, 724\u2013728 (2018).","journal-title":"Nature"},{"key":"1313_CR84","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41573-025-01172-x","volume":"24","author":"CM Polonio","year":"2025","unstructured":"Polonio, C. M., McHale, K. A., Sherr, D. H., Rubenstein, D. & Quintana, F. J. The aryl hydrocarbon receptor: a rehabilitated target for therapeutic immune modulation. Nat. Rev. Drug Discov. 24, 610\u2013630 (2025).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1313_CR85","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375\u2013388 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1313_CR86","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-018-0023-4","volume":"556","author":"AC Wendeln","year":"2018","unstructured":"Wendeln, A. C. et al. Innate immune memory in the brain shapes neurological disease hallmarks. Nature 556, 332\u2013338 (2018). This study describes epigenetic inflammatory memory in microglia in the context of disease.","journal-title":"Nature"},{"key":"1313_CR87","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-024-08165-7","volume":"636","author":"LC Hinte","year":"2024","unstructured":"Hinte, L. C. et al. Adipose tissue retains an epigenetic memory of obesity after weight loss. Nature 636, 457\u2013465 (2024).","journal-title":"Nature"},{"key":"1313_CR88","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41586-024-07187-5","volume":"627","author":"HG Lee","year":"2024","unstructured":"Lee, H. G. et al. Disease-associated astrocyte epigenetic memory promotes CNS pathology. Nature 627, 865\u2013872 (2024). This work is the first to report epigenetic inflammatory memory in astrocytes.","journal-title":"Nature"},{"key":"1313_CR89","doi-asserted-by":"publisher","first-page":"eabh2444","DOI":"10.1126\/science.abh2444","volume":"374","author":"KAU Gonzales","year":"2021","unstructured":"Gonzales, K. A. U. et al. Stem cells expand potency and alter tissue fitness by accumulating diverse epigenetic memories. Science 374, eabh2444 (2021).","journal-title":"Science"},{"key":"1313_CR90","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.stem.2021.07.001","volume":"28","author":"SB Larsen","year":"2021","unstructured":"Larsen, S. B. et al. Establishment, maintenance, and recall of inflammatory memory. Cell Stem Cell 28, 1758\u20131774.e8 (2021).","journal-title":"Cell Stem Cell"},{"key":"1313_CR91","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41586-022-04739-5","volume":"606","author":"JE Burda","year":"2022","unstructured":"Burda, J. E. et al. Divergent transcriptional regulation of astrocyte reactivity across disorders. Nature 606, 557\u2013564 (2022). This study defines transcriptional and epigenetic changes induced in astrocytes by lipopolysaccharide, spinal cord injury and EAE, identifying common regulators, including p300.","journal-title":"Nature"},{"key":"1313_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62995-1","volume":"16","author":"SI Lee","year":"2025","unstructured":"Lee, S. I. et al. Astrocyte priming enhances microglial A\u03b2 clearance and is compromised by APOE4. Nat. Commun. 16, 7551 (2025).","journal-title":"Nat. Commun."},{"key":"1313_CR93","doi-asserted-by":"publisher","first-page":"8411","DOI":"10.1523\/JNEUROSCI.2745-14.2015","volume":"35","author":"E Hennessy","year":"2015","unstructured":"Hennessy, E., Griffin, \u00c9. W. & Cunningham, C. Astrocytes are primed by chronic neurodegeneration to produce exaggerated chemokine and cell infiltration responses to acute stimulation with the cytokines IL-1\u03b2 and TNF-\u03b1. J. Neurosci. 35, 8411\u20138422 (2015).","journal-title":"J. Neurosci."},{"key":"1313_CR94","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41593-026-02208-0","volume":"29","author":"M Kabbe","year":"2026","unstructured":"Kabbe, M. et al. Single-nucleus epigenomic profiling of the adult human central nervous system unveils epigenetic memory of developmental programs. Nat. Neurosci. 29, 992\u20131006 (2026).","journal-title":"Nat. Neurosci."},{"key":"1313_CR95","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/s41593-025-02100-3","volume":"28","author":"C Zheng","year":"2025","unstructured":"Zheng, C. et al. Distinct transcriptomic and epigenomic responses of mature oligodendrocytes during disease progression in a mouse model of multiple sclerosis. Nat. Neurosci. 28, 2612\u20132627 (2025).","journal-title":"Nat. Neurosci."},{"key":"1313_CR96","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41380-025-03181-z","volume":"31","author":"G Yang","year":"2026","unstructured":"Yang, G. et al. Histone demethylase PHF2 regulates inflammatory genes in Alzheimer\u2019s disease. Mol. Psychiatry 31, 845\u2013859 (2026).","journal-title":"Mol. Psychiatry"},{"key":"1313_CR97","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.neuron.2025.11.006","volume":"114","author":"G Shammas","year":"2026","unstructured":"Shammas, G. et al. Neurons undergo IFN\u03b3-driven persistent epigenetic shifts and synaptopathy in encephalitis. Neuron 114, 622\u2013639.e11 (2026).","journal-title":"Neuron"},{"key":"1313_CR98","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41593-024-01580-z","volume":"27","author":"BLL Clayton","year":"2024","unstructured":"Clayton, B. L. L. et al. A phenotypic screening platform for identifying chemical modulators of astrocyte reactivity. Nat. Neurosci. 27, 656\u2013665 (2024).","journal-title":"Nat. Neurosci."},{"key":"1313_CR99","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00109-003-0469-0","volume":"81","author":"LF Chen","year":"2003","unstructured":"Chen, L. F. & Greene, W. C. Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. J. Mol. Med. 81, 549\u2013557 (2003).","journal-title":"J. Mol. Med."},{"key":"1313_CR100","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2147\/JIR.S140188","volume":"11","author":"S Giridharan","year":"2018","unstructured":"Giridharan, S. & Srinivasan, M. Mechanisms of NF-\u03baB p65 and strategies for therapeutic manipulation. J. Inflamm. Res. 11, 407\u2013419 (2018).","journal-title":"J. Inflamm. Res."},{"key":"1313_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64088-5","volume":"16","author":"S Park","year":"2025","unstructured":"Park, S. et al. NR3C1-mediated epigenetic regulation suppresses astrocytic immune responses in mice. Nat. Commun. 16, 8330 (2025).","journal-title":"Nat. Commun."},{"key":"1313_CR102","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41586-022-04419-4","volume":"603","author":"F Ingelfinger","year":"2022","unstructured":"Ingelfinger, F. et al. Twin study reveals non-heritable immune perturbations in multiple sclerosis. Nature 603, 152\u2013158 (2022).","journal-title":"Nature"},{"key":"1313_CR103","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.immuni.2023.04.013","volume":"56","author":"MG Kiss","year":"2023","unstructured":"Kiss, M. G. et al. Interleukin-3 coordinates glial-peripheral immune crosstalk to incite multiple sclerosis. Immunity 56, 1502\u20131514.e8 (2023).","journal-title":"Immunity"},{"key":"1313_CR104","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00401-021-02366-4","volume":"142","author":"M Gharagozloo","year":"2021","unstructured":"Gharagozloo, M. et al. Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation. Acta Neuropathol. 142, 899\u2013915 (2021).","journal-title":"Acta Neuropathol."},{"key":"1313_CR105","first-page":"4025","volume":"130","author":"T Chen","year":"2020","unstructured":"Chen, T. et al. Astrocyte-microglia interaction drives evolving neuromyelitis optica lesion. J. Clin. Invest. 130, 4025\u20134038 (2020).","journal-title":"J. Clin. Invest."},{"key":"1313_CR106","doi-asserted-by":"publisher","first-page":"957067","DOI":"10.3389\/fnmol.2022.957067","volume":"15","author":"S Lagalwar","year":"2022","unstructured":"Lagalwar, S. Mechanisms of tunneling nanotube-based propagation of neurodegenerative disease proteins. Front. Mol. Neurosci. 15, 957067 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"1313_CR107","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41586-025-09191-9","volume":"644","author":"BM Andersen","year":"2025","unstructured":"Andersen, B. M. et al. Barcoded viral tracing identifies immunosuppressive astrocyte-glioma interactions. Nature 644, 1097\u20131106 (2025). This study extends RABID-seq molecular barcoding-based analysis of cell\u2013cell interactions to clinical samples.","journal-title":"Nature"},{"key":"1313_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40982-8","volume":"14","author":"M Linnerbauer","year":"2023","unstructured":"Linnerbauer, M. et al. PD-L1 positive astrocytes attenuate inflammatory functions of PD-1 positive microglia in models of autoimmune neuroinflammation. Nat. Commun. 14, 5555 (2023).","journal-title":"Nat. Commun."},{"key":"1313_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39046-8","volume":"14","author":"I Molina-Gonzalez","year":"2023","unstructured":"Molina-Gonzalez, I. et al. Astrocyte-oligodendrocyte interaction regulates central nervous system regeneration. Nat. Commun. 14, 3372 (2023).","journal-title":"Nat. Commun."},{"key":"1313_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52142-7","volume":"15","author":"C Chen","year":"2024","unstructured":"Chen, C. et al. Astrocyte-derived clusterin disrupts glial physiology to obstruct remyelination in mouse models of demyelinating diseases. Nat. Commun. 15, 7791 (2024).","journal-title":"Nat. Commun."},{"key":"1313_CR111","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176910","volume":"134","author":"S Ghorbani","year":"2024","unstructured":"Ghorbani, S. et al. Fibulin-2 is an extracellular matrix inhibitor of oligodendrocytes relevant to multiple sclerosis. J. Clin. Invest. 134, e176910 (2024).","journal-title":"J. Clin. Invest."},{"key":"1313_CR112","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00018-022-04340-z","volume":"79","author":"H Lebas","year":"2022","unstructured":"Lebas, H. et al. PAI-1 production by reactive astrocytes drives tissue dysfibrinolysis in multiple sclerosis models. Cell Mol. Life Sci. 79, 323 (2022).","journal-title":"Cell Mol. Life Sci."},{"key":"1313_CR113","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41583-024-00823-z","volume":"25","author":"MS Woo","year":"2024","unstructured":"Woo, M. S., Engler, J. B. & Friese, M. A. The neuropathobiology of multiple sclerosis. Nat. Rev. Neurosci. 25, 493\u2013513 (2024).","journal-title":"Nat. Rev. Neurosci."},{"key":"1313_CR114","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/71555","volume":"6","author":"D Pitt","year":"2000","unstructured":"Pitt, D., Werner, P. & Raine, C. S. Glutamate excitotoxicity in a model of multiple sclerosis. Nat. Med. 6, 67\u201370 (2000).","journal-title":"Nat. Med."},{"key":"1313_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02948-x","volume":"20","author":"GE Denaroso","year":"2023","unstructured":"Denaroso, G. E. et al. Deletion of voltage-gated calcium channels in astrocytes decreases neuroinflammation and demyelination in a murine model of multiple sclerosis. J. Neuroinflammation 20, 263 (2023).","journal-title":"J. Neuroinflammation"},{"key":"1313_CR116","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.bbi.2024.07.010","volume":"121","author":"AM Baraibar","year":"2024","unstructured":"Baraibar, A. M. et al. Autoimmune inflammation triggers aberrant astrocytic calcium signaling to impair synaptic plasticity. Brain Behav. Immun. 121, 192\u2013210 (2024).","journal-title":"Brain Behav. Immun."},{"key":"1313_CR117","doi-asserted-by":"publisher","first-page":"a041353","DOI":"10.1101\/cshperspect.a041353","volume":"16","author":"MB Ahrens","year":"2024","unstructured":"Ahrens, M. B., Khakh, B. S. & Poskanzer, K. E. Astrocyte calcium signaling. Cold Spring Harb. Perspect. Biol. 16, a041353 (2024).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1313_CR118","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210998","volume":"219","author":"SZ Lu","year":"2022","unstructured":"Lu, S. Z. et al. Inhibition of astrocytic DRD2 suppresses CNS inflammation in an animal model of multiple sclerosis. J. Exp. Med. 219, e20210998 (2022).","journal-title":"J. Exp. Med."},{"key":"1313_CR119","doi-asserted-by":"publisher","DOI":"10.1172\/JCI164637","volume":"133","author":"J Kerkering","year":"2023","unstructured":"Kerkering, J. et al. iPSC-derived reactive astrocytes from patients with multiple sclerosis protect cocultured neurons in inflammatory conditions. J. Clin. Invest. 133, e164637 (2023).","journal-title":"J. Clin. Invest."},{"key":"1313_CR120","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature13835","volume":"518","author":"KK Farh","year":"2015","unstructured":"Farh, K. K. et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518, 337\u2013343 (2015).","journal-title":"Nature"},{"key":"1313_CR121","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav7188","volume":"365","author":"International Multiple Sclerosis Genetics Consortium.","year":"2019","unstructured":"International Multiple Sclerosis Genetics Consortium. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365, eaav7188 (2019).","journal-title":"Science"},{"key":"1313_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07785-8","volume":"9","author":"G Ponath","year":"2018","unstructured":"Ponath, G. et al. Enhanced astrocyte responses are driven by a genetic risk allele associated with multiple sclerosis. Nat. Commun. 9, 5337 (2018).","journal-title":"Nat. Commun."},{"key":"1313_CR123","doi-asserted-by":"publisher","first-page":"291ra293","DOI":"10.1126\/scitranslmed.aaa9223","volume":"7","author":"WJ Housley","year":"2015","unstructured":"Housley, W. J. et al. Genetic variants associated with autoimmunity drive NF\u03baB signaling and responses to inflammatory stimuli. Sci. Transl. Med. 7, 291ra293 (2015).","journal-title":"Sci. Transl. Med."},{"key":"1313_CR124","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature09342","volume":"467","author":"K Kim","year":"2010","unstructured":"Kim, K. et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285\u2013290 (2010).","journal-title":"Nature"},{"key":"1313_CR125","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.stemcr.2023.06.007","volume":"18","author":"VM Jovanovic","year":"2023","unstructured":"Jovanovic, V. M. et al. A defined roadmap of radial glia and astrocyte differentiation from human pluripotent stem cells. Stem Cell Rep. 18, 1701\u20131720 (2023).","journal-title":"Stem Cell Rep."},{"key":"1313_CR126","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jneuroim.2014.06.009","volume":"274","author":"RY Kim","year":"2014","unstructured":"Kim, R. Y. et al. Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis. J. Neuroimmunol. 274, 53\u201361 (2014).","journal-title":"J. Neuroimmunol."},{"key":"1313_CR127","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2017213118","volume":"118","author":"YM Khaw","year":"2021","unstructured":"Khaw, Y. M. et al. Astrocytes lure CXCR2-expressing CD4+ T cells to gray matter via TAK1-mediated chemokine production in a mouse model of multiple sclerosis. Proc. Natl Acad. Sci. USA 118, e2017213118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1313_CR128","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna, M. & Butovsky, O. Microglia function in the central nervous system during health and neurodegeneration. Annu. Rev. Immunol. 35, 441\u2013468 (2017).","journal-title":"Annu. Rev. Immunol."},{"key":"1313_CR129","doi-asserted-by":"publisher","first-page":"108835","DOI":"10.1016\/j.celrep.2021.108835","volume":"34","author":"K Shen","year":"2021","unstructured":"Shen, K. et al. Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination. Cell Rep. 34, 108835 (2021).","journal-title":"Cell Rep."},{"key":"1313_CR130","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev-immunol-093019-110159","volume":"39","author":"M Prinz","year":"2021","unstructured":"Prinz, M., Masuda, T., Wheeler, M. A. & Quintana, F. J. Microglia and central nervous system-associated macrophages-from origin to disease modulation. Annu. Rev. Immunol. 39, 251\u2013277 (2021).","journal-title":"Annu. Rev. Immunol."},{"key":"1313_CR131","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41586-019-0924-x","volume":"566","author":"T Masuda","year":"2019","unstructured":"Masuda, T. et al. Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution. Nature 566, 388\u2013392 (2019).","journal-title":"Nature"},{"key":"1313_CR132","doi-asserted-by":"publisher","first-page":"eaat7554","DOI":"10.1126\/science.aat7554","volume":"363","author":"MJC Jordao","year":"2019","unstructured":"Jordao, M. J. C. et al. Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation. Science 363, eaat7554 (2019). This work uncovers distinct transcriptional states of microglia and infiltrating or resident myeloid cells in EAE, clarifying their divergent roles during neuroinflammation.","journal-title":"Science"},{"key":"1313_CR133","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.immuni.2018.02.014","volume":"48","author":"D Mrdjen","year":"2018","unstructured":"Mrdjen, D. et al. High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity 48, 599 (2018).","journal-title":"Immunity"},{"key":"1313_CR134","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41586-025-09662-z","volume":"648","author":"P Ayata","year":"2025","unstructured":"Ayata, P. et al. Lymphoid gene expression supports neuroprotective microglia function. Nature 648, 157\u2013165 (2025). This study describes important novel roles for the expression of lymphoid genes in microglia.","journal-title":"Nature"},{"key":"1313_CR135","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","volume":"8","author":"H Lassmann","year":"2012","unstructured":"Lassmann, H., van Horssen, J. & Mahad, D. Progressive multiple sclerosis: pathology and pathogenesis. Nat. Rev. Neurol. 8, 647\u2013656 (2012).","journal-title":"Nat. Rev. Neurol."},{"key":"1313_CR136","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41590-020-0654-0","volume":"21","author":"AS Mendiola","year":"2020","unstructured":"Mendiola, A. S. et al. Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. Nat. Immunol. 21, 513\u2013524 (2020).","journal-title":"Nat. Immunol."},{"key":"1313_CR137","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/s41590-023-01522-0","volume":"24","author":"AS Mendiola","year":"2023","unstructured":"Mendiola, A. S. et al. Defining blood-induced microglia functions in neurodegeneration through multiomic profiling. Nat. Immunol. 24, 1173\u20131187 (2023).","journal-title":"Nat. Immunol."},{"key":"1313_CR138","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41593-021-00801-z","volume":"24","author":"Y Dong","year":"2021","unstructured":"Dong, Y. et al. Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia. Nat. Neurosci. 24, 489\u2013503 (2021).","journal-title":"Nat. Neurosci."},{"key":"1313_CR139","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40370-2","volume":"14","author":"P Sinner","year":"2023","unstructured":"Sinner, P. et al. Microglial expression of CD83 governs cellular activation and restrains neuroinflammation in experimental autoimmune encephalomyelitis. Nat. Commun. 14, 4601 (2023).","journal-title":"Nat. Commun."},{"key":"1313_CR140","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/1873-3468.13013","volume":"592","author":"G Campbell","year":"2018","unstructured":"Campbell, G. & Mahad, D. J. Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis. FEBS Lett. 592, 1113\u20131121 (2018).","journal-title":"FEBS Lett."},{"key":"1313_CR141","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-024-07167-9","volume":"628","author":"L Peruzzotti-Jametti","year":"2024","unstructured":"Peruzzotti-Jametti, L. et al. Mitochondrial complex I activity in microglia sustains neuroinflammation. Nature 628, 195\u2013203 (2024). This elegant work uncovers a novel relationship between microglial metabolism and CNS inflammation.","journal-title":"Nature"},{"key":"1313_CR142","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41586-023-06409-6","volume":"620","author":"LM Sanmarco","year":"2023","unstructured":"Sanmarco, L. M. et al. Lactate limits CNS autoimmunity by stabilizing HIF-1\u03b1 in dendritic cells. Nature 620, 881\u2013889 (2023).","journal-title":"Nature"},{"key":"1313_CR143","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1365-2990.1993.tb00431.x","volume":"19","author":"H Li","year":"1993","unstructured":"Li, H., Newcombe, J., Groome, N. P. & Cuzner, M. L. Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques. Neuropathol. Appl. Neurobiol. 19, 214\u2013223 (1993).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"1313_CR144","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00401-013-1082-0","volume":"125","author":"S Singh","year":"2013","unstructured":"Singh, S. et al. Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons. Acta Neuropathol. 125, 595\u2013608 (2013).","journal-title":"Acta Neuropathol."},{"key":"1313_CR145","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/ana.22521","volume":"70","author":"NM Moll","year":"2011","unstructured":"Moll, N. M. et al. Multiple sclerosis normal-appearing white matter: pathology-imaging correlations. Ann. Neurol. 70, 764\u2013773 (2011).","journal-title":"Ann. Neurol."},{"key":"1313_CR146","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08976-7","volume":"10","author":"M van der Poel","year":"2019","unstructured":"van der Poel, M. et al. Transcriptional profiling of human microglia reveals grey-white matter heterogeneity and multiple sclerosis-associated changes. Nat. Commun. 10, 1139 (2019).","journal-title":"Nat. Commun."},{"key":"1313_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46068-3","volume":"15","author":"AMR van den Bosch","year":"2024","unstructured":"van den Bosch, A. M. R. et al. Profiling of microglia nodules in multiple sclerosis reveals propensity for lesion formation. Nat. Commun. 15, 1667 (2024).","journal-title":"Nat. Commun."},{"key":"1313_CR148","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49312-y","volume":"15","author":"J Belien","year":"2024","unstructured":"Belien, J. et al. CHIT1 at diagnosis predicts faster disability progression and reflects early microglial activation in multiple sclerosis. Nat. Commun. 15, 5013 (2024).","journal-title":"Nat. Commun."},{"key":"1313_CR149","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nri.2017.125","volume":"18","author":"Q Li","year":"2018","unstructured":"Li, Q. & Barres, B. A. Microglia and macrophages in brain homeostasis and disease. Nat. Rev. Immunol. 18, 225\u2013242 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1313_CR150","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41583-023-00709-6","volume":"24","author":"F Dist\u00e9fano-Gagn\u00e9","year":"2023","unstructured":"Dist\u00e9fano-Gagn\u00e9, F., Bitarafan, S., Lacroix, S. & Gosselin, D. Roles and regulation of microglia activity in multiple sclerosis: insights from animal models. Nat. Rev. Neurosci. 24, 397\u2013415 (2023).","journal-title":"Nat. Rev. Neurosci."},{"key":"1313_CR151","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1084\/jem.173.4.801","volume":"173","author":"IY Chung","year":"1991","unstructured":"Chung, I. Y., Norris, J. G. & Benveniste, E. N. Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains. J. Exp. Med. 173, 801\u2013811 (1991).","journal-title":"J. Exp. Med."},{"key":"1313_CR152","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/0006-8993(89)90078-4","volume":"491","author":"M Sawada","year":"1989","unstructured":"Sawada, M., Kondo, N., Suzumura, A. & Marunouchi, T. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res. 491, 394\u2013397 (1989).","journal-title":"Brain Res."},{"key":"1313_CR153","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1084\/jem.164.2.594","volume":"164","author":"D Giulian","year":"1986","unstructured":"Giulian, D., Baker, T. J., Shih, L. C. & Lachman, L. B. Interleukin 1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164, 594\u2013604 (1986).","journal-title":"J. Exp. Med."},{"key":"1313_CR154","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1126\/science.3872478","volume":"228","author":"D Giulian","year":"1985","unstructured":"Giulian, D. & Lachman, L. B. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 228, 497\u2013499 (1985).","journal-title":"Science"},{"key":"1313_CR155","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-022-05534-y","volume":"613","author":"NB McNamara","year":"2023","unstructured":"McNamara, N. B. et al. Microglia regulate central nervous system myelin growth and integrity. Nature 613, 120\u2013129 (2023).","journal-title":"Nature"},{"key":"1313_CR156","doi-asserted-by":"publisher","first-page":"113574","DOI":"10.1016\/j.celrep.2023.113574","volume":"42","author":"CS Baaklini","year":"2023","unstructured":"Baaklini, C. S. et al. Microglia promote remyelination independent of their role in clearing myelin debris. Cell Rep. 42, 113574 (2023).","journal-title":"Cell Rep."},{"key":"1313_CR157","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s43587-023-00479-x","volume":"3","author":"X Li","year":"2023","unstructured":"Li, X. et al. Transcriptional and epigenetic decoding of the microglial aging process. Nat. Aging 3, 1288\u20131311 (2023).","journal-title":"Nat. Aging"},{"key":"1313_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02926-5","volume":"9","author":"M Olah","year":"2018","unstructured":"Olah, M. et al. A transcriptomic atlas of aged human microglia. Nat. Commun. 9, 539 (2018).","journal-title":"Nat. Commun."},{"key":"1313_CR159","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/nn.3469","volume":"16","author":"VE Miron","year":"2013","unstructured":"Miron, V. E. et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 16, 1211\u20131218 (2013).","journal-title":"Nat. Neurosci."},{"key":"1313_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22532-2","volume":"12","author":"A Sherafat","year":"2021","unstructured":"Sherafat, A., Pfeiffer, F., Reiss, A. M., Wood, W. M. & Nishiyama, A. Microglial neuropilin-1 promotes oligodendrocyte expansion during development and remyelination by trans-activating platelet-derived growth factor receptor. Nat. Commun. 12, 2265 (2021).","journal-title":"Nat. Commun."},{"key":"1313_CR161","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41593-020-00757-6","volume":"24","author":"SA Berghoff","year":"2021","unstructured":"Berghoff, S. A. et al. Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis. Nat. Neurosci. 24, 47\u201360 (2021).","journal-title":"Nat. Neurosci."},{"key":"1313_CR162","doi-asserted-by":"publisher","first-page":"112293","DOI":"10.1016\/j.celrep.2023.112293","volume":"42","author":"J Hou","year":"2023","unstructured":"Hou, J. et al. Transcriptomic atlas and interaction networks of brain cells in mouse CNS demyelination and remyelination. Cell Rep. 42, 112293 (2023).","journal-title":"Cell Rep."},{"key":"1313_CR163","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.immuni.2024.05.005","volume":"57","author":"KM Barclay","year":"2024","unstructured":"Barclay, K. M. et al. An inducible genetic tool to track and manipulate specific microglial states reveals their plasticity and roles in remyelination. Immunity 57, 1394\u20131412.e8 (2024).","journal-title":"Immunity"},{"key":"1313_CR164","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/s41590-022-01360-6","volume":"23","author":"Z Haimon","year":"2022","unstructured":"Haimon, Z. et al. Cognate microglia-T cell interactions shape the functional regulatory T cell pool in experimental autoimmune encephalomyelitis pathology. Nat. Immunol. 23, 1749\u20131762 (2022).","journal-title":"Nat. Immunol."},{"key":"1313_CR165","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190812","volume":"217","author":"B Wasser","year":"2020","unstructured":"Wasser, B. et al. CNS-localized myeloid cells capture living invading T cells during neuroinflammation. J. Exp. Med. 217, e20190812 (2020).","journal-title":"J. Exp. Med."},{"key":"1313_CR166","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1113\/jphysiol.1949.sp004335","volume":"108","author":"AF Huxley","year":"1949","unstructured":"Huxley, A. F. & Stampfli, R. Evidence for saltatory conduction in peripheral myelinated nerve fibres. J. Physiol. 108, 315\u2013339 (1949).","journal-title":"J. Physiol."},{"key":"1313_CR167","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1007\/s00018-013-1365-6","volume":"70","author":"F de Castro","year":"2013","unstructured":"de Castro, F., Bribian, A. & Ortega, M. C. Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology. Cell Mol. Life Sci. 70, 4355\u20134368 (2013).","journal-title":"Cell Mol. Life Sci."},{"key":"1313_CR168","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fnana.2015.00092","volume":"9","author":"F Perez-Cerda","year":"2015","unstructured":"Perez-Cerda, F., Sanchez-Gomez, M. V. & Matute, C. Pio del Rio Hortega and the discovery of the oligodendrocytes. Front. Neuroanat. 9, 92 (2015).","journal-title":"Front. Neuroanat."},{"key":"1313_CR169","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1212\/01.wnl.0000275228.13012.7b","volume":"68","author":"S Dhib-Jalbut","year":"2007","unstructured":"Dhib-Jalbut, S. Pathogenesis of myelin\/oligodendrocyte damage in multiple sclerosis. Neurology 68, S13\u2013S21 (2007).","journal-title":"Neurology"},{"key":"1313_CR170","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1093\/brain\/awq250","volume":"133","author":"S Bramow","year":"2010","unstructured":"Bramow, S. et al. Demyelination versus remyelination in progressive multiple sclerosis. Brain 133, 2983\u20132998 (2010).","journal-title":"Brain"},{"key":"1313_CR171","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.bbadis.2010.07.007","volume":"1812","author":"C Stadelmann","year":"2011","unstructured":"Stadelmann, C., Wegner, C. & Bruck, W. Inflammation, demyelination, and degeneration \u2014 recent insights from MS pathology. Biochim. Biophys. Acta 1812, 275\u2013282 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"1313_CR172","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1038\/s41591-018-0236-y","volume":"24","author":"AM Falc\u00e3o","year":"2018","unstructured":"Falc\u00e3o, A. M. et al. Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis. Nat. Med. 24, 1837\u20131844 (2018). This work reports the emergence, in the context of EAE, of MHC class I-expressing and MHC class II-expressing oligodendrocytes and OPCs, later termed immune oligodendroglia.","journal-title":"Nat. Med."},{"key":"1313_CR173","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11638-3","volume":"10","author":"L Kirby","year":"2019","unstructured":"Kirby, L. et al. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination. Nat. Commun. 10, 3887 (2019).","journal-title":"Nat. Commun."},{"key":"1313_CR174","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.82938","volume":"12","author":"EP Harrington","year":"2023","unstructured":"Harrington, E. P. et al. MHC class I and MHC class II reporter mice enable analysis of immune oligodendroglia in mouse models of multiple sclerosis. eLife 12, e82938 (2023).","journal-title":"eLife"},{"key":"1313_CR175","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41593-019-0369-4","volume":"22","author":"J Niu","year":"2019","unstructured":"Niu, J. et al. Aberrant oligodendroglial-vascular interactions disrupt the blood-brain barrier, triggering CNS inflammation. Nat. Neurosci. 22, 709\u2013718 (2019).","journal-title":"Nat. Neurosci."},{"key":"1313_CR176","first-page":"71","volume":"4","author":"HS Domingues","year":"2016","unstructured":"Domingues, H. S., Portugal, C. C., Socodato, R. & Relvas, J. B. Oligodendrocyte, astrocyte, and microglia crosstalk in myelin development, damage, and repair. Front. Cell Dev. Biol. 4, 71 (2016).","journal-title":"Front. Cell Dev. Biol."},{"key":"1313_CR177","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.cell.2024.11.038","volume":"188","author":"RE Handsaker","year":"2025","unstructured":"Handsaker, R. E. et al. Long somatic DNA-repeat expansion drives neurodegeneration in Huntington\u2019s disease. Cell 188, 623\u2013639.e19 (2025).","journal-title":"Cell"},{"key":"1313_CR178","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.4049\/jimmunol.1700834","volume":"200","author":"SJ Denstaedt","year":"2018","unstructured":"Denstaedt, S. J. et al. S100A8\/A9 drives neuroinflammatory priming and protects against anxiety-like behavior after sepsis. J. Immunol. 200, 3188\u20133200 (2018).","journal-title":"J. Immunol."},{"key":"1313_CR179","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","volume":"32","author":"JL Zamanian","year":"2012","unstructured":"Zamanian, J. L. et al. Genomic analysis of reactive astrogliosis. J. Neurosci. 32, 6391\u20136410 (2012).","journal-title":"J. Neurosci."},{"key":"1313_CR180","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.neuron.2021.12.034","volume":"110","author":"M Meijer","year":"2022","unstructured":"Meijer, M. et al. Epigenomic priming of immune genes implicates oligodendroglia in multiple sclerosis susceptibility. Neuron 110, 1193\u20131210 e1113 (2022). This study was the first demonstration that oligodendroglia exhibit epigenomic priming of immune gene programmes, linking their chromatin state to MS susceptibility.","journal-title":"Neuron"},{"key":"1313_CR181","doi-asserted-by":"publisher","first-page":"eadp6325","DOI":"10.1126\/science.adp6325","volume":"387","author":"JP Lin","year":"2025","unstructured":"Lin, J. P. et al. 4D marmoset brain map reveals MRI and molecular signatures for onset of multiple sclerosis-like lesions. Science 387, eadp6325 (2025).","journal-title":"Science"},{"key":"1313_CR182","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","volume":"172","author":"JS Tzartos","year":"2008","unstructured":"Tzartos, J. S. et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172, 146\u2013155 (2008).","journal-title":"Am. J. Pathol."},{"key":"1313_CR183","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1523\/JNEUROSCI.0849-14.2015","volume":"35","author":"S Moyon","year":"2015","unstructured":"Moyon, S. et al. Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration. J. Neurosci. 35, 4\u201320 (2015).","journal-title":"J. Neurosci."},{"key":"1313_CR184","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/ana.10764","volume":"55","author":"B Cannella","year":"2004","unstructured":"Cannella, B. & Raine, C. S. Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation. Ann. Neurol. 55, 46\u201357 (2004).","journal-title":"Ann. Neurol."},{"key":"1313_CR185","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1523\/JNEUROSCI.4689-06.2007","volume":"27","author":"R Balabanov","year":"2007","unstructured":"Balabanov, R. et al. Interferon-\u03b3-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis. J. Neurosci. 27, 2013\u20132024 (2007).","journal-title":"J. Neurosci."},{"key":"1313_CR186","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00401-012-0978-4","volume":"123","author":"K Markoullis","year":"2012","unstructured":"Markoullis, K. et al. Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathol. 123, 873\u2013886 (2012).","journal-title":"Acta Neuropathol."},{"key":"1313_CR187","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1073\/pnas.1901294117","volume":"117","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y. et al. Oligodendroglial connexin 47 regulates neuroinflammation upon autoimmune demyelination in a novel mouse model of multiple sclerosis. Proc. Natl Acad. Sci. USA 117, 2160\u20132169 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1313_CR188","doi-asserted-by":"publisher","first-page":"a020420","DOI":"10.1101\/cshperspect.a020420","volume":"7","author":"MV Sofroniew","year":"2014","unstructured":"Sofroniew, M. V. Astrogliosis. Cold Spring Harb. Perspect. Biol. 7, a020420 (2014).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1313_CR189","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.4049\/jimmunol.144.8.2999","volume":"144","author":"IY Chung","year":"1990","unstructured":"Chung, I. Y. & Benveniste, E. N. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J. Immunol. 144, 2999\u20133007 (1990).","journal-title":"J. Immunol."},{"key":"1313_CR190","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092649","volume":"9","author":"S Codeluppi","year":"2014","unstructured":"Codeluppi, S. et al. Interleukin-6 secretion by astrocytes is dynamically regulated by PI3K-mTOR-calcium signaling. PLoS One 9, e92649 (2014).","journal-title":"PLoS One"},{"key":"1313_CR191","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/cdd.2014.35","volume":"21","author":"M Bonora","year":"2014","unstructured":"Bonora, M. et al. Tumor necrosis factor-alpha impairs oligodendroglial differentiation through a mitochondria-dependent process. Cell Death Differ. 21, 1198\u20131208 (2014).","journal-title":"Cell Death Differ."},{"key":"1313_CR192","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/ana.23599","volume":"72","author":"LW Lau","year":"2012","unstructured":"Lau, L. W. et al. Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination. Ann. Neurol. 72, 419\u2013432 (2012).","journal-title":"Ann. Neurol."},{"key":"1313_CR193","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-019-1484-9","volume":"573","author":"M Segel","year":"2019","unstructured":"Segel, M. et al. Niche stiffness underlies the ageing of central nervous system progenitor cells. Nature 573, 130\u2013134 (2019).","journal-title":"Nature"},{"key":"1313_CR194","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.expneurol.2018.07.001","volume":"308","author":"AR Hackett","year":"2018","unstructured":"Hackett, A. R. et al. Injury type-dependent differentiation of NG2 glia into heterogeneous astrocytes. Exp. Neurol. 308, 72\u201379 (2018).","journal-title":"Exp. Neurol."},{"key":"1313_CR195","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nm974","volume":"10","author":"MS Windrem","year":"2004","unstructured":"Windrem, M. S. et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat. Med. 10, 93\u201397 (2004).","journal-title":"Nat. Med."},{"key":"1313_CR196","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14207-0","volume":"7","author":"N Suzuki","year":"2017","unstructured":"Suzuki, N. et al. Differentiation of oligodendrocyte precursor cells from Sox10-Venus mice to oligodendrocytes and astrocytes. Sci. Rep. 7, 14133 (2017).","journal-title":"Sci. Rep."},{"key":"1313_CR197","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fnmol.2015.00035","volume":"8","author":"A Alizadeh","year":"2015","unstructured":"Alizadeh, A., Dyck, S. M. & Karimi-Abdolrezaee, S. Myelin damage and repair in pathologic CNS: challenges and prospects. Front. Mol. Neurosci. 8, 35 (2015).","journal-title":"Front. Mol. Neurosci."},{"key":"1313_CR198","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nature11007","volume":"485","author":"U F\u00fcnfschilling","year":"2012","unstructured":"F\u00fcnfschilling, U. et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485, 517\u2013521 (2012). Together with Lee et al.199, this study describes the metabolic support of neurons by oligodendrocytes, resembling similar observations of astrocyte\u2013neuron interactions.","journal-title":"Nature"},{"key":"1313_CR199","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature11314","volume":"487","author":"Y Lee","year":"2012","unstructured":"Lee, Y. et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487, 443\u2013448 (2012).","journal-title":"Nature"},{"key":"1313_CR200","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.tins.2018.03.006","volume":"41","author":"MM Holm","year":"2018","unstructured":"Holm, M. M., Kaiser, J. & Schwab, M. E. Extracellular vesicles: multimodal envoys in neural maintenance and repair. Trends Neurosci. 41, 360\u2013372 (2018).","journal-title":"Trends Neurosci."},{"key":"1313_CR201","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1083\/jcb.200911018","volume":"189","author":"C Hsu","year":"2010","unstructured":"Hsu, C. et al. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J. Cell Biol. 189, 223\u2013232 (2010).","journal-title":"J. Cell Biol."},{"key":"1313_CR202","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001604","volume":"11","author":"C Fruhbeis","year":"2013","unstructured":"Fruhbeis, C. et al. Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol. 11, e1001604 (2013).","journal-title":"PLoS Biol."},{"key":"1313_CR203","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cmet.2020.05.019","volume":"32","author":"C Mukherjee","year":"2020","unstructured":"Mukherjee, C. et al. Oligodendrocytes provide antioxidant defense function for neurons by secreting ferritin heavy chain. Cell Metab. 32, 259\u2013272.e10 (2020).","journal-title":"Cell Metab."},{"key":"1313_CR204","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000700","volume":"7","author":"Y You","year":"2020","unstructured":"You, Y. et al. Chronic demyelination exacerbates neuroaxonal loss in patients with MS with unilateral optic neuritis. Neurol. Neuroimmunol. Neuroinflamm. 7, e700 (2020).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"1313_CR205","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/brain\/awn080","volume":"131","author":"KA Irvine","year":"2008","unstructured":"Irvine, K. A. & Blakemore, W. F. Remyelination protects axons from demyelination-associated axon degeneration. Brain 131, 1464\u20131477 (2008).","journal-title":"Brain"},{"key":"1313_CR206","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1016\/j.cell.2024.04.005","volume":"187","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Small-molecule-induced epigenetic rejuvenation promotes SREBP condensation and overcomes barriers to CNS myelin regeneration. Cell 187, 2465\u20132484.e22 (2024).","journal-title":"Cell"},{"key":"1313_CR207","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/BF00685250","volume":"63","author":"SK Ludwin","year":"1984","unstructured":"Ludwin, S. K. & Sternberger, N. H. An immunohistochemical study of myelin proteins during remyelination in the central nervous system. Acta Neuropathol. 63, 240\u2013248 (1984).","journal-title":"Acta Neuropathol."},{"key":"1313_CR208","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrn917","volume":"3","author":"RJ Franklin","year":"2002","unstructured":"Franklin, R. J. Why does remyelination fail in multiple sclerosis? Nat. Rev. Neurosci. 3, 705\u2013714 (2002).","journal-title":"Nat. Rev. Neurosci."},{"key":"1313_CR209","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/s41593-023-01366-9","volume":"26","author":"E Schaffner","year":"2023","unstructured":"Schaffner, E. et al. Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease. Nat. Neurosci. 26, 1218\u20131228 (2023).","journal-title":"Nat. Neurosci."},{"key":"1313_CR210","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrn2480","volume":"9","author":"RJ Franklin","year":"2008","unstructured":"Franklin, R. J. & Ffrench-Constant, C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 9, 839\u2013855 (2008).","journal-title":"Nat. Rev. Neurosci."},{"key":"1313_CR211","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.neuron.2023.05.001","volume":"111","author":"S Nocera","year":"2023","unstructured":"Nocera, S. & Chan, J. R. Remyelination by preexisting oligodendrocytes: glass half full or half empty? Neuron 111, 1689\u20131691 (2023).","journal-title":"Neuron"},{"key":"1313_CR212","doi-asserted-by":"publisher","first-page":"E11807","DOI":"10.1073\/pnas.1808064115","volume":"115","author":"ID Duncan","year":"2018","unstructured":"Duncan, I. D. et al. The adult oligodendrocyte can participate in remyelination. Proc. Natl Acad. Sci. USA 115, E11807\u2013E11816 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1313_CR213","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41586-018-0842-3","volume":"566","author":"MSY Yeung","year":"2019","unstructured":"Yeung, M. S. Y. et al. Dynamics of oligodendrocyte generation in multiple sclerosis. Nature 566, 538\u2013542 (2019).","journal-title":"Nature"},{"key":"1313_CR214","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.neuron.2023.03.031","volume":"111","author":"A Mezydlo","year":"2023","unstructured":"Mezydlo, A. et al. Remyelination by surviving oligodendrocytes is inefficient in the inflamed mammalian cortex. Neuron 111, 1748\u20131759.e8 (2023).","journal-title":"Neuron"},{"key":"1313_CR215","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56092-6","volume":"16","author":"G Della-Flora Nunes","year":"2025","unstructured":"Della-Flora Nunes, G. et al. Incomplete remyelination via therapeutically enhanced oligodendrogenesis is sufficient to recover visual cortical function. Nat. Commun. 16, 732 (2025).","journal-title":"Nat. Commun."},{"key":"1313_CR216","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00401-019-02073-1","volume":"139","author":"A Fernandez-Castaneda","year":"2020","unstructured":"Fernandez-Castaneda, A. et al. The active contribution of OPCs to neuroinflammation is mediated by LRP1. Acta Neuropathol. 139, 365\u2013382 (2020).","journal-title":"Acta Neuropathol."},{"key":"1313_CR217","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","volume":"97","author":"C Baecher-Allan","year":"2018","unstructured":"Baecher-Allan, C., Kaskow, B. J. & Weiner, H. L. Multiple sclerosis: mechanisms and immunotherapy. Neuron 97, 742\u2013768 (2018).","journal-title":"Neuron"},{"key":"1313_CR218","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jama.2020.26858","volume":"325","author":"MP McGinley","year":"2021","unstructured":"McGinley, M. P., Goldschmidt, C. H. & Rae-Grant, A. D. Diagnosis and treatment of multiple sclerosis: a review. JAMA 325, 765\u2013779 (2021).","journal-title":"JAMA"},{"key":"1313_CR219","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41582-023-00801-6","volume":"19","author":"L Klotz","year":"2023","unstructured":"Klotz, L., Antel, J. & Kuhlmann, T. Inflammation in multiple sclerosis: consequences for remyelination and disease progression. Nat. Rev. Neurol. 19, 305\u2013320 (2023).","journal-title":"Nat. Rev. Neurol."},{"key":"1313_CR220","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S1474-4422(21)00237-4","volume":"20","author":"DS Reich","year":"2021","unstructured":"Reich, D. S. et al. Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 20, 729\u2013738 (2021).","journal-title":"Lancet Neurol."},{"key":"1313_CR221","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa2415988","volume":"392","author":"RJ Fox","year":"2025","unstructured":"Fox, R. J. et al. Tolebrutinib in nonrelapsing secondary progressive multiple sclerosis. N. Engl. J. Med. 392, 1883\u20131892 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1313_CR222","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41582-023-00800-7","volume":"19","author":"J Kr\u00e4mer","year":"2023","unstructured":"Kr\u00e4mer, J., Bar-Or, A., Turner, T. J. & Wiendl, H. Bruton tyrosine kinase inhibitors for multiple sclerosis. Nat. Rev. Neurol. 19, 289\u2013304 (2023).","journal-title":"Nat. Rev. Neurol."},{"key":"1313_CR223","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54430-8","volume":"15","author":"RC Gruber","year":"2024","unstructured":"Gruber, R. C. et al. BTK regulates microglial function and neuroinflammation in human stem cell models and mouse models of multiple sclerosis. Nat. Commun. 15, 10116 (2024).","journal-title":"Nat. Commun."},{"key":"1313_CR224","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1093\/brain\/awab231","volume":"144","author":"K Pellerin","year":"2021","unstructured":"Pellerin, K. et al. MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response. Brain 144, 2361\u20132374 (2021).","journal-title":"Brain"},{"key":"1313_CR225","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-024-02730-0","volume":"147","author":"A Geladaris","year":"2024","unstructured":"Geladaris, A. et al. BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repair. Acta Neuropathol. 147, 75 (2024).","journal-title":"Acta Neuropathol."},{"key":"1313_CR226","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3233\/BPL-200100","volume":"5","author":"E Martin","year":"2020","unstructured":"Martin, E. et al. Bruton\u2019s tyrosine kinase inhibition promotes myelin repair. Brain Plast. 5, 123\u2013133 (2020).","journal-title":"Brain Plast."},{"key":"1313_CR227","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3390\/ijms23010355","volume":"23","author":"CG Yu","year":"2021","unstructured":"Yu, C. G. et al. Inhibition of bruton tyrosine kinase reduces neuroimmune cascade and promotes recovery after spinal cord injury. Int. J. Mol. Sci. 23, 355 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1313_CR228","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1007\/s10072-023-07259-w","volume":"45","author":"AA Hamad","year":"2024","unstructured":"Hamad, A. A., Amer, B. E., Hawas, Y., Mabrouk, M. A. & Meshref, M. Masitinib as a neuroprotective agent: a scoping review of preclinical and clinical evidence. Neurol. Sci. 45, 1861\u20131873 (2024).","journal-title":"Neurol. Sci."},{"key":"1313_CR229","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-12-36","volume":"12","author":"P Vermersch","year":"2012","unstructured":"Vermersch, P. et al. Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study. BMC Neurol. 12, 36 (2012).","journal-title":"BMC Neurol."},{"key":"1313_CR230","doi-asserted-by":"publisher","first-page":"15107","DOI":"10.3390\/ijms131115107","volume":"13","author":"M Costanza","year":"2012","unstructured":"Costanza, M., Colombo, M. P. & Pedotti, R. Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis. Int. J. Mol. Sci. 13, 15107\u201315125 (2012).","journal-title":"Int. J. Mol. Sci."},{"key":"1313_CR231","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00294-0","volume":"8","author":"SB Mkaddem","year":"2017","unstructured":"Mkaddem, S. B. et al. Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation. Nat. Commun. 8, 246 (2017).","journal-title":"Nat. Commun."},{"key":"1313_CR232","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-10-21","volume":"10","author":"E Ingley","year":"2012","unstructured":"Ingley, E. Functions of the Lyn tyrosine kinase in health and disease. Cell Commun. Signal. 10, 21 (2012).","journal-title":"Cell Commun. Signal."},{"key":"1313_CR233","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu, H., Lin, L., Zhang, Z., Zhang, H. & Hu, H. Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study. Signal. Transduct. Target. Ther. 5, 209 (2020).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1313_CR234","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001148","volume":"9","author":"P Vermersch","year":"2022","unstructured":"Vermersch, P. et al. Efficacy and safety of masitinib in progressive forms of multiple sclerosis: a randomized, phase 3, clinical trial. Neurol. Neuroimmunol. Neuroinflamm. 9, e1148 (2022).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"1313_CR235","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s11064-023-04073-w","volume":"49","author":"LD Bobermin","year":"2024","unstructured":"Bobermin, L. D. et al. Simvastatin differentially modulates glial functions in cultured cortical and hypothalamic astrocytes derived from interferon \u03b1\/\u03b2 receptor knockout mice. Neurochem. Res. 49, 732\u2013743 (2024).","journal-title":"Neurochem. Res."},{"key":"1313_CR236","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1093\/brain\/aww113","volume":"139","author":"L Mayo","year":"2016","unstructured":"Mayo, L. et al. IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammation. Brain 139, 1939\u20131957 (2016).","journal-title":"Brain"},{"key":"1313_CR237","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/biof.1597","volume":"46","author":"H Bagheri","year":"2020","unstructured":"Bagheri, H. et al. The effects of statins on microglial cells to protect against neurodegenerative disorders: a mechanistic review. Biofactors 46, 309\u2013325 (2020).","journal-title":"Biofactors"},{"key":"1313_CR238","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-014-0085-7","volume":"7","author":"MA Churchward","year":"2014","unstructured":"Churchward, M. A. & Todd, K. G. Statin treatment affects cytokine release and phagocytic activity in primary cultured microglia through two separable mechanisms. Mol. Brain 7, 85 (2014).","journal-title":"Mol. Brain"},{"key":"1313_CR239","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/S0140-6736(13)62242-4","volume":"383","author":"J Chataway","year":"2014","unstructured":"Chataway, J. et al. Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial. Lancet 383, 2213\u20132221 (2014).","journal-title":"Lancet"},{"key":"1313_CR240","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.2353\/ajpath.2009.080947","volume":"174","author":"VE Miron","year":"2009","unstructured":"Miron, V. E. et al. Statin therapy inhibits remyelination in the central nervous system. Am. J. Pathol. 174, 1880\u20131890 (2009).","journal-title":"Am. J. Pathol."},{"key":"1313_CR241","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-086414","volume":"14","author":"J Blackstone","year":"2024","unstructured":"Blackstone, J. et al. Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK. BMJ Open 14, e086414 (2024).","journal-title":"BMJ Open"},{"key":"1313_CR242","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.expneurol.2008.01.022","volume":"211","author":"I Luccarini","year":"2008","unstructured":"Luccarini, I. et al. Combined treatment with atorvastatin and minocycline suppresses severity of EAE. Exp. Neurol. 211, 214\u2013226 (2008).","journal-title":"Exp. Neurol."},{"key":"1313_CR243","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1212\/WNL.0b013e31824f7fdd","volume":"78","author":"E Waubant","year":"2012","unstructured":"Waubant, E. et al. Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study. Neurology 78, 1171\u20131178 (2012).","journal-title":"Neurology"},{"key":"1313_CR244","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1056\/NEJMoa1803583","volume":"379","author":"RJ Fox","year":"2018","unstructured":"Fox, R. J. et al. Phase 2 trial of ibudilast in progressive multiple sclerosis. N. Engl. J. Med. 379, 846\u2013855 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1313_CR245","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.neuropharm.2003.09.009","volume":"46","author":"T Mizuno","year":"2004","unstructured":"Mizuno, T. et al. Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia. Neuropharmacology 46, 404\u2013411 (2004).","journal-title":"Neuropharmacology"},{"key":"1313_CR246","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1517\/14656560903426189","volume":"10","author":"P Rolan","year":"2009","unstructured":"Rolan, P., Hutchinson, M. & Johnson, K. Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease. Expert Opin. Pharmacother. 10, 2897\u20132904 (2009).","journal-title":"Expert Opin. Pharmacother."},{"key":"1313_CR247","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41582-024-01050-x","volume":"21","author":"PA Muraro","year":"2025","unstructured":"Muraro, P. A. et al. Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder \u2014 recommendations from ECTRIMS and the EBMT. Nat. Rev. Neurol. 21, 140\u2013158 (2025).","journal-title":"Nat. Rev. Neurol."},{"key":"1313_CR248","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2018.18743","volume":"321","author":"RK Burt","year":"2019","unstructured":"Burt, R. K. et al. Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial. JAMA 321, 165\u2013174 (2019).","journal-title":"JAMA"},{"key":"1313_CR249","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16427","volume":"31","author":"B Braun","year":"2024","unstructured":"Braun, B. et al. Exploring the therapeutic potential of autologous hematopoietic stem cell transplantation in progressive multiple sclerosis-a systematic review. Eur. J. Neurol. 31, e16427 (2024).","journal-title":"Eur. J. Neurol."},{"key":"1313_CR250","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/brain\/awaf286","volume":"149","author":"T Kalincik","year":"2025","unstructured":"Kalincik, T. et al. Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis. Brain 149, 951\u2013962 (2025).","journal-title":"Brain"},{"key":"1313_CR251","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41591-022-02097-3","volume":"29","author":"A Genchi","year":"2023","unstructured":"Genchi, A. et al. Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study. Nat. Med. 29, 75\u201385 (2023).","journal-title":"Nat. Med."},{"key":"1313_CR252","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.stem.2023.11.001","volume":"30","author":"MA Leone","year":"2023","unstructured":"Leone, M. A. et al. Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis. Cell Stem Cell 30, 1597\u20131609.e8 (2023).","journal-title":"Cell Stem Cell"},{"key":"1313_CR253","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13287-024-03765-6","volume":"15","author":"VK Harris","year":"2024","unstructured":"Harris, V. K. et al. Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results from a phase II, randomized, placebo-controlled clinical trial. Stem Cell Res. Ther. 15, 151 (2024).","journal-title":"Stem Cell Res. Ther."},{"key":"1313_CR254","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1093\/brain\/awaa333","volume":"143","author":"P Petrou","year":"2020","unstructured":"Petrou, P. et al. Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis. Brain 143, 3574\u20133588 (2020).","journal-title":"Brain"},{"key":"1313_CR255","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S1474-4422(21)00301-X","volume":"20","author":"A Uccelli","year":"2021","unstructured":"Uccelli, A. et al. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial. Lancet Neurol. 20, 917\u2013929 (2021).","journal-title":"Lancet Neurol."},{"key":"1313_CR256","doi-asserted-by":"publisher","first-page":"107658","DOI":"10.1016\/j.celrep.2020.107658","volume":"31","author":"MS Windrem","year":"2020","unstructured":"Windrem, M. S. et al. Human glial progenitor cells effectively remyelinate the demyelinated adult brain. Cell Rep. 31, 107658 (2020).","journal-title":"Cell Rep."},{"key":"1313_CR257","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.stemcr.2014.06.012","volume":"3","author":"P Douvaras","year":"2014","unstructured":"Douvaras, P. et al. Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells. Stem Cell Rep. 3, 250\u2013259 (2014).","journal-title":"Stem Cell Rep."},{"key":"1313_CR258","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1474-4422(23)00377-0","volume":"23","author":"B Zierfuss","year":"2024","unstructured":"Zierfuss, B., Larochelle, C. & Prat, A. Blood-brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies. Lancet Neurol. 23, 95\u2013109 (2024).","journal-title":"Lancet Neurol."},{"key":"1313_CR259","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.it.2005.08.014","volume":"26","author":"L Steinman","year":"2005","unstructured":"Steinman, L. & Zamvil, S. S. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol. 26, 565\u2013571 (2005).","journal-title":"Trends Immunol."},{"key":"1313_CR260","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/nn.3168","volume":"15","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff, R. M. Animal models of multiple sclerosis: the good, the bad and the bottom line. Nat. Neurosci. 15, 1074\u20131077 (2012).","journal-title":"Nat. Neurosci."},{"key":"1313_CR261","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","volume":"21","author":"SS Soldan","year":"2023","unstructured":"Soldan, S. S. & Lieberman, P. M. Epstein-Barr virus and multiple sclerosis. Nat. Rev. Microbiol. 21, 51\u201364 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"1313_CR262","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41582-023-00775-5","volume":"19","author":"K Bjornevik","year":"2023","unstructured":"Bjornevik, K., Munz, C., Cohen, J. I. & Ascherio, A. Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Nat. Rev. Neurol. 19, 160\u2013171 (2023).","journal-title":"Nat. Rev. Neurol."},{"key":"1313_CR263","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-024-07134-4","volume":"627","author":"S Nakandakari-Higa","year":"2024","unstructured":"Nakandakari-Higa, S. et al. Universal recording of immune cell interactions in vivo. Nature 627, 399\u2013406 (2024). This study describes a powerful approach to studying cell\u2013cell interactions in vivo.","journal-title":"Nature"},{"key":"1313_CR264","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1002\/cne.24040","volume":"524","author":"CS von Bartheld","year":"2016","unstructured":"von Bartheld, C. S., Bahney, J. & Herculano-Houzel, S. The search for true numbers of neurons and glial cells in the human brain: a review of 150 years of cell counting. J. Comp. Neurol. 524, 3865\u20133895 (2016).","journal-title":"J. Comp. Neurol."},{"key":"1313_CR265","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","volume":"24","author":"C Escartin","year":"2021","unstructured":"Escartin, C. et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat. Neurosci. 24, 312\u2013325 (2021).","journal-title":"Nat. Neurosci."},{"key":"1313_CR266","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli, R. C. et al. Microglia states and nomenclature: a field at its crossroads. Neuron 110, 3458\u20133483 (2022).","journal-title":"Neuron"},{"key":"1313_CR267","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1002\/glia.22836","volume":"63","author":"AV Molofsky","year":"2015","unstructured":"Molofsky, A. V. & Deneen, B. Astrocyte development: a guide for the perplexed. Glia 63, 1320\u20131329 (2015).","journal-title":"Glia"},{"key":"1313_CR268","doi-asserted-by":"publisher","first-page":"R326","DOI":"10.1016\/j.cub.2021.01.056","volume":"31","author":"P Hasel","year":"2021","unstructured":"Hasel, P. & Liddelow, S. A. Astrocytes. Curr. Biol. 31, R326\u2013R327 (2021).","journal-title":"Curr. Biol."},{"key":"1313_CR269","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature12776","volume":"504","author":"WS Chung","year":"2013","unstructured":"Chung, W. S. et al. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature 504, 394\u2013400 (2013).","journal-title":"Nature"},{"key":"1313_CR270","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41586-020-03060-3","volume":"590","author":"JH Lee","year":"2021","unstructured":"Lee, J. H. et al. Astrocytes phagocytose adult hippocampal synapses for circuit homeostasis. Nature 590, 612\u2013617 (2021).","journal-title":"Nature"},{"key":"1313_CR271","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1146\/annurev-neuro-070918-050443","volume":"42","author":"BS Khakh","year":"2019","unstructured":"Khakh, B. S. & Deneen, B. The emerging nature of astrocyte diversity. Annu. Rev. Neurosci. 42, 187\u2013207 (2019).","journal-title":"Annu. Rev. Neurosci."},{"key":"1313_CR272","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.tins.2025.06.009","volume":"48","author":"W Kwon","year":"2025","unstructured":"Kwon, W., Williamson, M. R. & Deneen, B. A functional perspective on astrocyte heterogeneity. Trends Neurosci. 48, 691\u2013705 (2025).","journal-title":"Trends Neurosci."},{"key":"1313_CR273","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41593-020-0602-1","volume":"23","author":"OA Bayraktar","year":"2020","unstructured":"Bayraktar, O. A. et al. Astrocyte layers in the mammalian cerebral cortex revealed by a single-cell in situ transcriptomic map. Nat. Neurosci. 23, 500\u2013509 (2020).","journal-title":"Nat. Neurosci."},{"key":"1313_CR274","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.neuron.2017.06.029","volume":"95","author":"H Chai","year":"2017","unstructured":"Chai, H. et al. Neural circuit-specialized astrocytes: transcriptomic, proteomic, morphological, and functional evidence. Neuron 95, 531\u2013549.e9 (2017).","journal-title":"Neuron"},{"key":"1313_CR275","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1194637","volume":"330","author":"F Ginhoux","year":"2010","unstructured":"Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841\u2013845 (2010). A landmark study on the origin of microglia.","journal-title":"Science"},{"key":"1313_CR276","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41583-024-00813-1","volume":"25","author":"L Barry-Carroll","year":"2024","unstructured":"Barry-Carroll, L. & Gomez-Nicola, D. The molecular determinants of microglial developmental dynamics. Nat. Rev. Neurosci. 25, 414\u2013427 (2024).","journal-title":"Nat. Rev. Neurosci."},{"key":"1313_CR277","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/j.devcel.2022.07.015","volume":"57","author":"DA Menassa","year":"2022","unstructured":"Menassa, D. A. et al. The spatiotemporal dynamics of microglia across the human lifespan. Dev. Cell 57, 2127\u20132139.e6 (2022).","journal-title":"Dev. Cell"},{"key":"1313_CR278","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41586-023-06002-x","volume":"618","author":"T Lazarov","year":"2023","unstructured":"Lazarov, T., Juarez-Carre\u00f1o, S., Cox, N. & Geissmann, F. Physiology and diseases of tissue-resident macrophages. Nature 618, 698\u2013707 (2023).","journal-title":"Nature"},{"key":"1313_CR279","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41583-018-0057-5","volume":"19","author":"O Butovsky","year":"2018","unstructured":"Butovsky, O. & Weiner, H. L. Microglial signatures and their role in health and disease. Nat. Rev. Neurosci. 19, 622\u2013635 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"1313_CR280","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3390\/cells8111424","volume":"8","author":"S Kuhn","year":"2019","unstructured":"Kuhn, S., Gritti, L., Crooks, D. & Dombrowski, Y. Oligodendrocytes in development, myelin generation and beyond. Cells 8, 1424 (2019).","journal-title":"Cells"},{"key":"1313_CR281","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41583-020-00379-8","volume":"21","author":"W Xin","year":"2020","unstructured":"Xin, W. & Chan, J. R. Myelin plasticity: sculpting circuits in learning and memory. Nat. Rev. Neurosci. 21, 682\u2013694 (2020).","journal-title":"Nat. Rev. Neurosci."},{"key":"1313_CR282","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41593-022-01104-7","volume":"25","author":"M Kenigsbuch","year":"2022","unstructured":"Kenigsbuch, M. et al. A shared disease-associated oligodendrocyte signature among multiple CNS pathologies. Nat. Neurosci. 25, 876\u2013886 (2022).","journal-title":"Nat. Neurosci."},{"key":"1313_CR283","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.it.2024.08.003","volume":"45","author":"G Castelo-Branco","year":"2024","unstructured":"Castelo-Branco, G., Kukanja, P., Guerreiro-Cacais, A. O. & Rubio Rodriguez-Kirby, L. A. Disease-associated oligodendroglia: a putative nexus in neurodegeneration. Trends Immunol. 45, 750\u2013759 (2024).","journal-title":"Trends Immunol."},{"key":"1313_CR284","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik, K. et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375, 296\u2013301 (2022). This landmark study provides compelling evidence linking EBV to MS.","journal-title":"Science"},{"key":"1313_CR285","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41586-025-09378-0","volume":"646","author":"F Laderach","year":"2025","unstructured":"Laderach, F. et al. EBV induces CNS homing of B cells attracting inflammatory T cells. Nature 646, 171\u2013179 (2025).","journal-title":"Nature"},{"key":"1313_CR286","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192109","volume":"13","author":"A Hassani","year":"2018","unstructured":"Hassani, A., Corboy, J. R., Al-Salam, S. & Khan, G. Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells. PLoS One 13, e0192109 (2018).","journal-title":"PLoS One"},{"key":"1313_CR287","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2425670122","volume":"122","author":"N Orr","year":"2025","unstructured":"Orr, N. & Steinman, L. Epstein-Barr virus and the immune microenvironment in multiple sclerosis: Insights from high-dimensional brain tissue imaging. Proc. Natl Acad. Sci. USA 122, e2425670122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1313_CR288","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/glia.20640","volume":"56","author":"L Favre-Kontula","year":"2008","unstructured":"Favre-Kontula, L. et al. GlialCAM, an immunoglobulin-like cell adhesion molecule is expressed in glial cells of the central nervous system. Glia 56, 633\u2013645 (2008).","journal-title":"Glia"},{"key":"1313_CR289","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","volume":"603","author":"TV Lanz","year":"2022","unstructured":"Lanz, T. V. et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603, 321\u2013327 (2022).","journal-title":"Nature"}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41577-026-01313-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-026-01313-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-026-01313-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:01:51Z","timestamp":1793106111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41577-026-01313-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":289,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1313"],"URL":"https:\/\/doi.org\/10.1038\/s41577-026-01313-2","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"5 May 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}